Numis announced Spire Healthcare Group (LON:SPI), upholding its stock price target at 360.00GBX today
- Updated: October 2, 2016
In a statement issued on 9/28/2016 Numis hold steady the target price of Spire Healthcare Group (LON:SPI) from 360.00GBX to 360.00GBX indicating a possible downside of -0.09%.
Previously on Friday September 09, 2016, Berenberg reported about Spire Healthcare Group (LON:SPI) held steady the target price at 395.00GBX. At the time, this indicated a possible upside of 0.08%.
Yesterday Spire Healthcare Group (LON:SPI) traded 1.13% higher at 396.65GBX. The company’s 50-day moving average is 364.75GBX and its 200-day moving average is 345.02GBX. The last stock close price is up 13.28% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 618,122 shares of the stock were exchanged, up from an average trading volume of 457,973
See Chart Below
Spire Healthcare Group has a 52 week low of 275.00GBX and a 52 week high of 411.00GBX with a P/E ratio of 24.28 The company’s market cap is currently 0 GBX.
In addition to Numis reporting its target price, a total of 7 firms have reported on the stock. The consensus target price is 57.14GBX with 1 firm rating the stock a strong buy, 4 firms rating the stock a buy, 4 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.
About Spire Healthcare Group (LON:SPI)
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The Company offers a range of primary care, consulting and diagnostic services. The Company's serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The Company's primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.